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Summary Disagreement exists between different COPD guidelines considering
classification of severity of the disease. The aim of our study was to determine
whether there is any correlation between severity scales of various COPD guidelines
(ATS, BTS, ERS and GOLD) and the frequency of hospitalisations for COPD
exacerbation. A cohort of 67 COPD patients (65 male–2 female, 45 ex-smokers, 22
current smokers, aged (69.471.1)) was recruited from those admitted in the
pulmonary clinic of the University Hospital of Heraklion, Crete for an acute
exacerbation. Lung function tests and arterial blood gases analyses were performed
during stable conditions at a scheduled visit 2 months after discharge. The patients
were stratified using the FEV1 percent-predicted measurement of this visit into mild,
moderate and severe in accordance to the ATS, BTS, ERS and GOLD scales of severity.
The number of hospitalisations for acute exacerbation was recorded for the following
18 months. A total of 165 exacerbations were recorded. The correlation between the
severity of COPD and the number of hospitalisations per year was statistically
significant using the GOLD classification system of severity (P¼ 0.02 and r¼ 0.294). A
weak correlation was also found between the number of hospitalisations and the ERS
classification system (P¼ 0.05 and r¼ 0.24). No statistically significant correlation
was found between the number of hospitalisations and the ATS or BTS severity scales.
In conclusion the GOLD and ERS classification systems of severity of COPD correlated
to exacerbations causing hospitalisation. The same was not true for the ATS and BTS
severity scales. Better correlation was achieved with the GOLD scale.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Chronic obstructive pulmonary disease (COPD) is
one of the major health problems worldwide. It is
currently the third leading cause of death and by
the year 2020 it is expected to become the fifth
cause of morbidity and mortality.1 The recent
introduction of various guidelines for the manage-
ment of COPD2–5 aimed to standardise the diagnosis
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and management of this disease and therefore
provide means of prevention and better treatment
for the patients. Nowadays, among the most
commonly used guidelines are the consensus state-
ment of the European Respiratory Society (ERS)
published in August 1995,3 the American Thoracic
Society (ATS) standards statement published in
November 1995,5 the guidelines of the British
Thoracic Society (BTS) published in December
19974 and finally the Global Initiative for Chronic
Obstructive Lung diseases (GOLD) guidelines, re-
ported early in 2001.6 The GOLD guidelines were
developed by the National Heart Lung, and Blood
Institute of USA and the World Health Organisation
in an international effort to create a globally
applicable report on the diagnosis and management
of COPD.6
All four guideline papers report scales of severity
of the disease, which are based primarily on the
level of reduction of FEV1. Important differences
are found between these classification scales,
which often cause confusion in every-day clinical
practice and in research. These differences are
partly due to the lack of evidence-based informa-
tion, so that classifications are based on empirical
consensus of experts in the field.6
Apart from these discrepancies there is also lack
of knowledge on any relationship between severity
scales and important outcomes, such as quality of
life, number of exacerbations, number of hospital
admissions and survival. Patients with COPD fre-
quently develop exacerbations that require hospi-
talisation and hospital care for these patients is
expensive, while long-term outcomes are relatively
poor.7 The aim of this study was to compare the
existing four classification systems of severity and
find out which correlates better to the frequency of
hospitalisations.
Materials and methods
Study design and patient selection
Between January 1999 and June 2000, a total of 67
COPD patients entered the study. The recruitment
of COPD patients was made using clinical criteria
from those admitted for an acute exacerbation in
the pulmonary clinic of the University Hospital of
Heraklion Crete, Greece. A screening visit was
scheduled 2 months after the day of discharge. At
this visit a brief medical history was taken, while
spirometry, lung volumesFusing the helium dilu-
tion techniqueFand the lung transfer factor for
carbon monoxide (KCO) (corrected for the haemo-
globin)Fusing the single breath method8Fwere
measured with a computerised system (MasterLab,
Jaeger 2.12, Germany). Arterial blood gases were
also measured at rest in the upright position
(AVL330, Switzerland). The FEV1 measurement of
the screening visit was used to group patients
according to diagnosis based on FEV1/VC criteria
and staging based on FEV1 criteria of each set of
staging (ATS, BTS, ERS, GOLD). Predicted values
were obtained from the standardised lung function
testing of the European Community for Steel and
Coal Luxembourg 1993.8
Thereafter all data concerning hospital admis-
sions for a COPD exacerbation of the cohort were
recorded prospectively over 18 months. Exacerba-
tions were defined in terms of symptoms according
to the criteria of Anthonisen et al.9 Briefly, a
patient was considered to be in acute exacerbation
when presented with increased dyspnea, increased
sputum volume and/or sputum purulence. Hospita-
lisation was decided according to the judgement of
the pulmonologist on duty following the ERS
guidelines.3 Pulmolonogists who decided on pa-
tient’s hospitalisation were kept blind to the
baseline spirometry results. Exclusion criteria of
the study included the co-existence of other
disease that could indicate hospital admission
regardless the severity of COPD exacerbation
(e.g. heart failure). Patients presenting reversibil-
ity of FEV1X15% of predicted after bronchodilation
were also excluded from the study, to eliminate the
possibility of co-existing asthma.
Statistical analysis
The r by c w2 test was used to investigate two-way
contingency tables that consisted of the categories
of the disease severity and the number of hospital
admissions per patient per year as independent
variables forming r rows and c columns. Spearman’s
rank correlation (Rho) was used in order to detect
association between severity stage as independent
and number of admissions per patient per year as
dependent variable. A P less than 0.05 was taken as
statistical significant. The software StatsDirect for
Windows version 2.2.3 (Camcode; Cambridge, UK)
was used for the analysis.
Results
The classification criteria of the severity of COPD
according to the four main guideline reports are
shown in Table 1. The same FEV1 measurement
(stable condition) was used to stratify the patients
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in mild, moderate and severe stage by ATS, BTS,
ERS, GOLD scales. Spirometry, diffusing capacity,
arterial blood gases and the number of patients
receiving long-term oxygen therapy (LTOT) are
shown in Table 2. The stratification of the patients
and the number of admissions, along with mortality
rates, according to the four different classification
systems of severity are shown in Table 3. All
patients included in the study fulfilled the criteria
for COPD in all four sets of staging. A statistically
significant positive correlation was found between
the stage of COPD according to the GOLD classifica-
tion system and the number of hospitalisations per
year (P¼ 0.02, r¼ 0.294). A weaker correlation was
found between the ERS classification system and
hospital admissions per year (P¼ 0.05 and
r¼ 0.240). No statistically significant correlation
was found considering the ATS and BTS severity
scales.
Discussion
The main result of this study was that when the
number of hospital admissions per year was used as
standard outcome, the classification of severity of
COPD proposed by the GOLD guidelines stratified
best COPD patients. The ERS severity scale corre-
lated weaker than the GOLD scale to the frequency
of hospitalisations, while the ATS and BTS did not
correlate significantly. Therefore, the GOLD classi-
fication system exceeds the others in terms of
prediction on the possibility of a COPD patient to
suffer a severe exacerbation that needs hospital
treatment.
The continuous revision of diagnostic criteria for
a particular disease is not uncommon in medicine.
According to the ATS, BTS and ERS guidelines the
classification of severity of the disease is based
exclusively on the percentage of predicted FEV1. In
the recently reported GOLD statement for the first
time symptoms plus spirometric results are com-
bined in assessing disease severity (Table 2). An
additional stepFstage 0Fwas introduced in an
attempt to detect patients at risk presenting with
minor symptoms and normal spirometry.6 Moreover,
GOLD statement splits stage II in stage IIA and IIB.6
It is obvious that a fundamental disagreement in
classifying COPD severity exists among the four
main guideline reports. For example, a patient with
FEV1 of 55% predicted is characterised as mild by
the ATS standards, moderate by the ERS and BTS
standards and moderate, stage IIB, by the GOLD
standards. This example clearly illustrates that in
every day practice these different classification
approaches could cause significant confusion in the
management of COPD. Moreover, in the research
field, any comparison of results between studies
using different classification scales is practically
not valid.
The present study is trying to compare the
severity scales of four different COPD guidelines
using a single outcome in the same cohort. In the
past there has been effort to validate COPD
guidelines, but without any comparison between
them. Two previous studies have showed that the
ATS or the BTS staging of severity of COPD separate
patients according to impairments in their health
status.10,11 We choose the number of severe
exacerbation needing management in the hospital
as valid outcome of comparison, because we
believe that the total number of exacerbations
including the milder ones treated at home cannot
be precisely quantified. Moreover, it is known that
there is a tendency to the patients to underreport
their exacerbations, especially the mild ones.12 On
the other hand, though it has been reported that
health-related quality of life questionnaires
(HrQoL) correlate to disease severity,13 patient’s
perception, psychological characteristics and co-
morbidity are important modifiers of the HrQoL
scores,11 which could cause a significant selection
bias in any cohort of patients.
Although the number of hospital admissions
seems to be a relatively objective outcome
associated with COPD severity, hospital admission
for a COPD exacerbation partly depends on the
physician’s assessment of the severity of the
exacerbation. Indeed, this is a limitation in our
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Table 1 Spirometric criteria of classification of COPD severity according to the ATS, BTS, ERS and GOLD
guidelines.
Mild COPD Moderate COPD Severe COPD
ATS FEV1X50% 49%XFEV1X35% 35%4FEV1
BTS 79%XFEV1X60% 59%XFEV1X40% 40%4FEV1
ERS FEV1X70% 69%XFEV1X50% 50%4FEV1
GOLD FEV1X80% Stage IIA Stage IIB 30%4FEV1
80%4FEV1X50% 50%FEV1X30%
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Table 2 Spirometry, RV/TLC, KCO, arterial blood gases and number of patients on long-term oxygen therapy (LTOT) classified according to the four severity scales.
ATS BTS ERS GOLD
Mild
n ¼ 3;
age¼ 69.7
Moderate
n ¼ 19;
age 63.5
Severe
n ¼ 45;
age¼ 69.2
Mild
n ¼ 1;
age ¼ 71
Moderate
n ¼ 10;
age¼ 68.2
Severe
n ¼ 56;
age¼ 69.7
Mild Moderate
n ¼ 3;
age¼ 69.9
Severe
n ¼ 64;
age¼ 68.9
Mild Moderate
n ¼ 39;
age¼ 69.9
Severe
n ¼ 28
age¼ 68.9
FVC (% pred.) 7673.9 5477.3 4077.9 8574.1 5678.9 42.678.9 76713.8 4479 76713.8 4479
FEV1 (% pred.) 6.2673.9 4074 26.974.8 6573.8 4472.9 28.975.9 62.573.4 30.877.6 IIA: 61.673
IIB:3675
23.979
RV/TLC 123711 14174 14678 128711 13777 135713 11079 13679.5 10978 13375.5
KCO (% pred.) 8979 7476 6775 89 7774 6879 73712 6474 7672 6275
PaO2 (mmHg) 59717.2 55711.6 50712.3 76742 4879 53.9712 59717 53712 54712 4878
PaCO2 (mmHg) 4179.9 54722.8 56716 5173.7 48710.9 54.9715.7 4777 5377 4876 5278
Patients on LTOT 3 16 42 1 9 51 3 58 35 IIA:3 IIB:32 26
Mortality (%) 0 10 4 0 0 7 0 6 IIA:0 IIB:8 4
Table 3 Distribution of COPD patients and their hospital admissions per year, according to the ATS, BTS, ERS and GOLD classification systems of COPD.
Mild COPD Moderate COPD Severe COPD
Patients Admissions Admission/
person/year
Patients Admissions Admission/
person/year
Patients Admissions Admission/
person/year
ATS 3 3 1 19 43 2.26 45 119 2.64
BTS 1 1 1 10 19 1.9 56 145 2.26
ERS 0 0 0 3 3 1 64 162 2.53
GOLD 0 0 0 39 81 2.07 28 84 3
IIA:2 2 1
IIB:37 79 2.14
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study, but we believe it did not seriously affect our
results, since the same doctors of the same
department following the same instructions for
assessment and management of an acute exacer-
bation evaluated all patients of this cohort. It could
be also suggested that the presence of other
confounding conditions might have influenced the
criteria for hospital admissions of our patients.
However, patients suffering from concomitant
systemic diseases (e.g. heart failure) were ex-
cluded from the study.
As it can be noticed in Table 2, a relatively small
cohort of patients was followed and almost all
patients were classified as moderate or severe. We
were not able to recruit a larger cohort because
recruitment was made from those COPD patients
admitted for an acute exacerbation who satisfied
the inclusion and exclusion criteria. Including
patients from the outpatient clinic would rather
provide us a larger cohort of patients and could
give different results. However, there would be
many mild patients, without severe exacerbations
and it would not be possible to record at least
one exacerbation in every patient. The lack of
mild patients, who are rarely admitted to the
hospital, does not weaken our results because the
aim of our study was to investigate which scale of
severity of COPD better correlates to hospital
admissions.
A few studies so far have tried to correlate
patient’s characteristics with the number of COPD
exacerbations per year. It has been shown that
factors predisposing to mild exacerbations are not
exactly the same with the ones predisposing to
severe acute exacerbation needing hospital admis-
sions. Miravitles and colleagues in a recent study
showed that increasing age, impairment of FEV1
and the presence of chronic mucus hypersecretion
are important risk factors associated independently
with COPD exacerbation.14 On the other hand, FEV1
impairment and significant co-morbidity increased
the risk for hospital admission in the same study.14
These findings agree with the results of the present
study, since the reduction of FEV1 in the more
severe stages of the disease, according to the GOLD
and ERS guidelines, correlated to the number of
admissions per year. Other studies have also found
a relationship between spirometry results and
COPD exacerbations.15,16 Emerman and colleagues
have reported that an FEV1 of less than 40%
identifies with high sensitivity patients who require
hospital admission for an acute exacerbation.16 In
contrast, Osman et al. failed to find any relation
between the percentage predicted of FEV1 and the
number of re-admissions within 12 months among a
cohort of COPD patients.17
In the present study other disease outcomes, like
lung volumes, KCO, blood gases were also measured
(Table 2). Although significant differences were
observed in the above measurements between the
four classification systems, results were generally
in agreement with the disease severity stage in all
four systems, except for the PaO2 and the PaCO2 in
the BTS. Table 2 also shows the number of patients
receiving long-term oxygen therapy, as well as
mortality rates in each severity stage. Paradoxi-
cally, patients classified as mild in the ATS and in
the BTS scale were under long-term oxygen therapy
and mortality rates were higher in moderate than
in severe stage in the ATS and GOLD severity scales.
Taken together these data indicate that when the
evaluation of classification systems of COPD is
based on a different outcome than admissions for
an exacerbation, results may not always be in
favour of GOLD system.
In summary, this study showed important differ-
ences in physiological parameters, treatment
modalities and most important, hospitalisation
rates between four classification systems of
severity of COPD. In the GOLD and ERS guidelines,
severity stages of COPD correlated positively
and significantly to the number of hospital admis-
sions per year. Best correlation was found with
the GOLD guidelines. Our finding provides evidence
that the GOLD classification system of severity
predicts better the number of hospital admissions
for an acute exacerbation. However, a number
of other host factors and outcomes should be
taken into account in the evaluation of severity
scales of COPD. Further studies, with large
cohorts of patients, must be done to identify the
scale which best corresponds to important
disease outcomes, such is the frequency of exacer-
bations.
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